GREG CUNY to Protein Synthesis Inhibitors
This is a "connection" page, showing publications GREG CUNY has written about Protein Synthesis Inhibitors.
Connection Strength
0.074
-
FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein. J Mol Neurosci. 2004; 24(1):129-36.
Score: 0.057
-
RNA therapeutics directed to the non coding regions of APP mRNA, in vivo anti-amyloid efficacy of paroxetine, erythromycin, and N-acetyl cysteine. Curr Alzheimer Res. 2006 Jul; 3(3):221-7.
Score: 0.017